AAPL, CDTX, QBTS, ASELS: Market End of Day Evaluation

Key Developments in the Markets

At the stock markets, the end-of-day evaluation is shaping up with significant developments, especially in the technology and biotechnology sectors. Apple’s (AAPL) launch of the iPhone 17 series in China has increased the company's sales by 22%. In the first month after the launch, the iPhone 17 accounted for three-quarters of smartphone sales in China, marking a remarkable success.

Merck and Cidara Agreement

On the other hand, Merck (MRK) is approaching an important acquisition agreement with the biotechnology firm Cidara Therapeutics (CDTX). According to reports by The Financial Times, this agreement is expected to involve a payment exceeding Cidara's approximately $3.3 billion market value. This move is seen as a step that will support Merck's strategic expansion in the biotechnology field.

D-Wave and CEO Sale

The large sale of shares by D-Wave Quantum (QBTS) CEO Alan E. Baratz has drawn attention in the markets. On November 11, Baratz sold a total of 806,288 shares for $23.2 million. This situation may create uncertainty among investors.

ASELS and KARSN's Export Agreements

Aselsan (ASELS) has taken an important step in the defense industry by signing export contracts worth a total of 153.8 million TL. Additionally, Karsan (KARSN) signed a comprehensive agreement with the Timișoara Municipality in Romania to sell 30 units of 10-meter e-ATA vehicles, 30 slow charging stations, and 15 pantograph charging stations for approximately 17 million euros.

Hat-San Ship’s Investment Project

Hat-San Ship (HATSN) announced that it has successfully completed the construction of its floating dock investment project. These developments are seen as a significant milestone for the company's future projections.

For investors, it would be beneficial to consider this information in their strategic decision-making processes. However, it should be noted that the information here does not constitute investment advice.